EcoDrugPlus

Ensembl ID : ML064942a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML064952a
Gene Symbol: -
External references: -
304 Possible Orthologues:

Ensembl ID : ML064957a
Gene Symbol: -
External references: -
193 Possible Orthologues:

Ensembl ID : ML065312a
Gene Symbol: -
External references: -
95 Possible Orthologues:

Ensembl ID : ML065711a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML065712a
Gene Symbol: -
External references: -
105 Possible Orthologues:

Ensembl ID : ML065728a
Gene Symbol: -
External references: -
117 Possible Orthologues:

Ensembl ID : ML066521a
Gene Symbol: -
External references: -
212 Possible Orthologues:

Ensembl ID : ML067114a
Gene Symbol: -
External references: -
75 Possible Orthologues:

Ensembl ID : ML067116a
Gene Symbol: -
External references: -
238 Possible Orthologues:

Ensembl ID : ML06751a
Gene Symbol: -
External references: -
430 Possible Orthologues:

Ensembl ID : ML050915a
Gene Symbol: -
External references: -
47 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).